期刊文献+

阿司匹林抵抗的研究进展 被引量:3

Research Progress of Aspirin Resistanc
下载PDF
导出
摘要 血小板在动脉粥样硬化斑块的形成和斑块破裂后的急性血栓事件中起关键作用,阿司匹林可有效抑制血小板聚集,血栓形成显著减少。阿司匹林被广泛用于心脑血管疾病一级预防和二级预防,但仍有大量患者发生血栓事件,如阿司匹林治疗失败或阿司匹林抵抗。阿司匹林抵抗经常伴随着不稳定斑块、心血管事件和脑血管意外的高发病率。研究表明,阿司匹林可减少血栓素A_2的生成,但不完全抑制血小板的活性。 Platelets play a key role in the formation of atherosclerotic plaques and acute thrombotic events after plaque rupture.Aspirin can effectively inhibit platelet aggregation and thrombosis is significantly reduced.Aspirin is the most widely prescribed drug for the primary and secondary prevention of cardiovascular and cerebrovascular diseases.However,a large number of patients taking aspirin therapy continue to experience thromboembolic events,a phenomenon referred to as aspirin resistance or treatment failure.Aspirin resistance is often associated with a high incidence of unstable plaque,cardiovascular events and cerebrovascular accident.The study has shown that aspirin reduces the formation of thromboxane A 2,but does not completely inhibit the activity of platelets.
作者 孙涛 于建设 SUN Tao;YU Jianshe(Inner Mongolia Medical University,Hohhot 010000,China;Department of Anesthesiology,Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010000,China)
出处 《医学综述》 2018年第5期853-857,共5页 Medical Recapitulate
基金 内蒙古自治区自然科学基金(2015MS0832)
关键词 阿司匹林抵抗 单核酸多态性 炎症 代谢综合征 微RNA Aspirin resistance Single nucleotide polymorphisms Inflammation Metabolic syndrome MicroRNA
  • 相关文献

参考文献1

二级参考文献10

  • 1规范应用阿司匹林治疗缺血性脑血管病的专家共识[J].中华内科杂志,2006,45(1):81-82. 被引量:76
  • 2O'Brien JR. Effects of salicylates on human platelets. Lancet, 1968,1 : 779-783.
  • 3Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol, 1971,6(9) :231-235.
  • 4Diener HC, Cunha L, Forbes C, et al. European stroke prevention study 2: dipyfidamole and acelylsalicylic acid in the secondary prevention of stroke. J Neurol SCI, 1996,143(1-2): 1- 13.
  • 5Savcic M, Hauert J, Bachmann F, et al. Clopidogrel loading dose regimes: kinetic profile of pharmacodynamic responses in healthy subjects. Semin Thromb Haemost, 1999,25Suppl 2:15- 19.
  • 6Helft G, Osende JI, Worthley SG, et al. Acute antithrombotic effect of clopidogrel in patients with atherosclerosis on aspirin. Arterioscler Thromb Vasc Biol, 2000,20( 10): 2316-2321.
  • 7Patrono C, Coller B, Fitzgerald GA, et al. Platelet-active drugs the relationships among dose, effctiveness, and side effects: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest, 2004,126: 234S-264S.
  • 8Coller BS. Blockade of platelet GP Ⅱ b/Ⅲ a receptors as an antithrombotic strategy. Circulation, 1995,92: 2373-2380.
  • 9The symphony investigators. Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomized trial. Lancet,2000,355(9201): 337- 345.
  • 10黄震华.新型抗血小板药物拉米非班[J].中国新药与临床杂志,2001,20(3):211-213. 被引量:14

共引文献11

同被引文献63

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部